Parotid and Cervical Nodal Status Predict Prognosis for Patients With Head and Neck Metastatic Cutaneous Squamous Cell Carcinoma
MetadataShow full item record
Background and Objectives: The appreciation of parotid involvement being an independent prognostic factor for metastatic cutaneous squamous cell carcinoma (SCC) is relatively new. A more comprehensive clinical staging system that separates parotid (P) from neck (N) disease, and further stratifies the N category has been proposed [O'Brien et al., Head Neck 2002; 24: 417-422]. This paper presents the clinical outcome of patients with head and neck metastatic cutaneous SCC treated at the four major head & neck surgical oncology centers in New Zealand and tests the proposed staging system, with modifications for pathological staging. Methods: Patients treated with a curative intent from 1990 to 2005 were identified and re-staged. Survival rates were calculated using the Kaplan-Meier method, and curves were compared with the log-rank test. Multivariate analysis using the Cox regression model was performed to assess the impact of each proposed P and N sub-group, and other parameters. Results and Conclusions: One hundred and seventy patients were identified. The 5-year disease-specific survival rate was 69%, and the locoregional recurrence rate was 36%. The presence of parotid (P<0.01) or neck (P=0.01) disease, immunosuppression (P<0.01) and the uptake of radiotherapy (P<0.01) impacted significantly on survival. Increasing P or N category worsened the prognosis significantly.
Journal of Surgical Oncology